407 related articles for article (PubMed ID: 27044532)
1. Clinical trial design and rationale of the Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 (MOMENTUM 3) investigational device exemption clinical study protocol.
Heatley G; Sood P; Goldstein D; Uriel N; Cleveland J; Middlebrook D; Mehra MR;
J Heart Lung Transplant; 2016 Apr; 35(4):528-36. PubMed ID: 27044532
[TBL] [Abstract][Full Text] [Related]
2. Hemocompatibility-Related Outcomes in the MOMENTUM 3 Trial at 6 Months: A Randomized Controlled Study of a Fully Magnetically Levitated Pump in Advanced Heart Failure.
Uriel N; Colombo PC; Cleveland JC; Long JW; Salerno C; Goldstein DJ; Patel CB; Ewald GA; Tatooles AJ; Silvestry SC; John R; Caldeira C; Jeevanandam V; Boyle AJ; Sundareswaran KS; Sood P; Mehra MR
Circulation; 2017 May; 135(21):2003-2012. PubMed ID: 28385948
[TBL] [Abstract][Full Text] [Related]
3. Association of Clinical Outcomes With Left Ventricular Assist Device Use by Bridge to Transplant or Destination Therapy Intent: The Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 (MOMENTUM 3) Randomized Clinical Trial.
Goldstein DJ; Naka Y; Horstmanshof D; Ravichandran AK; Schroder J; Ransom J; Itoh A; Uriel N; Cleveland JC; Raval NY; Cogswell R; Suarez EE; Lowes BD; Kim G; Bonde P; Sheikh FH; Sood P; Farrar DJ; Mehra MR
JAMA Cardiol; 2020 Apr; 5(4):411-419. PubMed ID: 31939996
[TBL] [Abstract][Full Text] [Related]
4. Five-Year Outcomes in Patients With Fully Magnetically Levitated vs Axial-Flow Left Ventricular Assist Devices in the MOMENTUM 3 Randomized Trial.
Mehra MR; Goldstein DJ; Cleveland JC; Cowger JA; Hall S; Salerno CT; Naka Y; Horstmanshof D; Chuang J; Wang A; Uriel N
JAMA; 2022 Sep; 328(12):1233-1242. PubMed ID: 36074476
[TBL] [Abstract][Full Text] [Related]
5. Fully Magnetically Levitated Left Ventricular Assist System for Treating Advanced HF: A Multicenter Study.
Netuka I; Sood P; Pya Y; Zimpfer D; Krabatsch T; Garbade J; Rao V; Morshuis M; Marasco S; Beyersdorf F; Damme L; Schmitto JD
J Am Coll Cardiol; 2015 Dec; 66(23):2579-2589. PubMed ID: 26670056
[TBL] [Abstract][Full Text] [Related]
6. Heartmate 3 fully magnetically levitated left ventricular assist device for the treatment of advanced heart failure -1 year results from the Ce mark trial.
Krabatsch T; Netuka I; Schmitto JD; Zimpfer D; Garbade J; Rao V; Morshuis M; Beyersdorf F; Marasco S; Damme L; Pya Y
J Cardiothorac Surg; 2017 Apr; 12(1):23. PubMed ID: 28376837
[TBL] [Abstract][Full Text] [Related]
7. Early outcomes with durable left ventricular assist device replacement using the HeartMate 3.
Barac YD; Wojnarski CM; Junpaparp P; Jawitz OK; Billard H; Daneshmand MA; Agrawal R; Devore A; Patel CB; Schroder JN; Milano CA
J Thorac Cardiovasc Surg; 2020 Jul; 160(1):132-139.e1. PubMed ID: 31740114
[TBL] [Abstract][Full Text] [Related]
8. Impact of Race on Clinical Outcomes After Implantation With a Fully Magnetically Levitated Left Ventricular Assist Device: An Analysis From the MOMENTUM 3 Trial.
Sheikh FH; Ravichandran AK; Goldstein DJ; Agarwal R; Ransom J; Bansal A; Kim G; Cleveland JC; Uriel N; Sheridan BC; Chomsky D; Patel SR; Dirckx N; Franke A; Mehra MR
Circ Heart Fail; 2021 Oct; 14(10):e008360. PubMed ID: 34525837
[TBL] [Abstract][Full Text] [Related]
9. Effects of centrifugal, axial, and pulsatile left ventricular assist device support on end-organ function in heart failure patients.
Kamdar F; Boyle A; Liao K; Colvin-adams M; Joyce L; John R
J Heart Lung Transplant; 2009 Apr; 28(4):352-9. PubMed ID: 19332262
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive Analysis of Stroke in the Long-Term Cohort of the MOMENTUM 3 Study.
Colombo PC; Mehra MR; Goldstein DJ; Estep JD; Salerno C; Jorde UP; Cowger JA; Cleveland JC; Uriel N; Sayer G; Skipper ER; Downey FX; Ono M; Hooker R; Anyanwu AC; Givertz MM; Mahr C; Topuria I; Somo SI; Crandall DL; Horstmanshof DA
Circulation; 2019 Jan; 139(2):155-168. PubMed ID: 30586698
[TBL] [Abstract][Full Text] [Related]
11. Effects of a fully magnetically levitated centrifugal-flow or axial-flow left ventricular assist device on von Willebrand factor: A prospective multicenter clinical trial.
Bansal A; Uriel N; Colombo PC; Narisetty K; Long JW; Bhimaraj A; Cleveland JC; Goldstein DJ; Stulak JM; Najjar SS; Lanfear DE; Adler ED; Dembitsky WP; Somo SI; Crandall DL; Chen D; Connors JM; Mehra MR
J Heart Lung Transplant; 2019 Aug; 38(8):806-816. PubMed ID: 31147187
[TBL] [Abstract][Full Text] [Related]
12. Impact of age, sex, therapeutic intent, race and severity of advanced heart failure on short-term principal outcomes in the MOMENTUM 3 trial.
Goldstein DJ; Mehra MR; Naka Y; Salerno C; Uriel N; Dean D; Itoh A; Pagani FD; Skipper ER; Bhat G; Raval N; Bruckner BA; Estep JD; Cogswell R; Milano C; Fendelander L; O'Connell JB; Cleveland J;
J Heart Lung Transplant; 2018 Jan; 37(1):7-14. PubMed ID: 29154131
[TBL] [Abstract][Full Text] [Related]
13. Use of left ventricular assist device (HeartMate II): a Singapore experience.
Lim CP; Sivathasan C; Tan TE; Lim CH; Kerk KL; Sim DK
Artif Organs; 2014 Jul; 38(7):543-8. PubMed ID: 24392937
[TBL] [Abstract][Full Text] [Related]
14. HeartMate® II continuous-flow left ventricular assist system.
Sheikh FH; Russell SD
Expert Rev Med Devices; 2011 Jan; 8(1):11-21. PubMed ID: 21158536
[TBL] [Abstract][Full Text] [Related]
15. Aspirin and left ventricular assist devices: rationale and design for the international randomized, placebo-controlled, non-inferiority ARIES HM3 trial.
Mehra MR; Crandall DL; Gustafsson F; Jorde UP; Katz JN; Netuka I; Uriel N; Connors JM; Sood P; Heatley G; Pagani FD
Eur J Heart Fail; 2021 Jul; 23(7):1226-1237. PubMed ID: 34142415
[TBL] [Abstract][Full Text] [Related]
16. Evolving trends in mechanical circulatory support: Clinical development of a fully magnetically levitated durable ventricular assist device.
Sidhu K; Lam PH; Mehra MR
Trends Cardiovasc Med; 2020 May; 30(4):223-229. PubMed ID: 31201005
[TBL] [Abstract][Full Text] [Related]
17. Using left ventricular assist devices in advanced heart failure patients.
Shah SR; Issa Najim N; Shah SA; Shahnawaz W; Ahmed Jangda M
J Community Hosp Intern Med Perspect; 2018; 8(6):357-359. PubMed ID: 30559944
[TBL] [Abstract][Full Text] [Related]
18. Left Ventricular Assist Device Design Reduces von Willebrand Factor Degradation: A Comparative Study Between the HeartMate II and the EVAHEART Left Ventricular Assist System.
Bartoli CR; Kang J; Zhang D; Howard J; Acker M; Atluri P; Motomura T
Ann Thorac Surg; 2017 Apr; 103(4):1239-1244. PubMed ID: 27717422
[TBL] [Abstract][Full Text] [Related]
19. A Fully Magnetically Levitated Circulatory Pump for Advanced Heart Failure.
Mehra MR; Naka Y; Uriel N; Goldstein DJ; Cleveland JC; Colombo PC; Walsh MN; Milano CA; Patel CB; Jorde UP; Pagani FD; Aaronson KD; Dean DA; McCants K; Itoh A; Ewald GA; Horstmanshof D; Long JW; Salerno C;
N Engl J Med; 2017 Feb; 376(5):440-450. PubMed ID: 27959709
[TBL] [Abstract][Full Text] [Related]
20. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.
John R; Pagani FD; Naka Y; Boyle A; Conte JV; Russell SD; Klodell CT; Milano CA; Rogers J; Farrar DJ; Frazier OH
J Thorac Cardiovasc Surg; 2010 Jul; 140(1):174-81. PubMed ID: 20447659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
